🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) NCT07086521Phase 11 site📍 Palo Alto Restem, LLC. · Tests: ULSC, Placebo T-cell Therapy in Patients With PML NCT06990087Phase 27 sites📍 München📍 Marburg📍 Hanover Hannover Medical School · Tests: Application of T-lymphocytes ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR) NCT06415487Phase 19 sites📍 San Diego📍 Denver📍 Nashville Acepodia Biotech, Inc. · Tests: Cyclophosphamide, Fludarabine, ACE2016, Pembrolizumab CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases NCT05827835Phase 1, Phase 21 site📍 Hangzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention NCT06686108Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Azacitidine (AZA) Days 1 - 5, Decitabine (DAC), Venetoclax Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies NCT07284433Phase 1, Phase 213 sites📍 Chicago📍 Evanston📍 Providence AvenCell Therapeutics, Inc. · Tests: Cyclophosphamide (Non-IMP, Lymphodepletion), Fludarabine (Non-IMP, Lymphodepletion), Allo-QuadCAR01-T Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC NCT07500220Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma NCT07645690EARLY Phase 13 sites📍 Beijing📍 Beijing📍 Beijing Chinese PLA General Hospital · Tests: CLEAR CAR-T cell injection AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation NCT06281496NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: AlloCare UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes NCT06751199NA1 site📍 Shanghai Shanghai Changzheng Hospital · Tests: human umbilical cord mesenchymal stem cells, allogeneic islet Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment NCT06904599Phase 21 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Human chorionic gonadotropin (hCG), Prednisone, Dexamethasone Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas NCT06176690Phase 12 sites📍 Houston📍 Houston Baylor College of Medicine · Tests: C7R.CD30.CAR-EBVST cells Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD NCT07364617Phase 21 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Fecal microbiota transplantation (FMT) Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial NCT06355583Phase 28 sites📍 Birmingham📍 Leeds📍 London Imperial College London · Tests: EBX-102, Placebo A Study of Human Allogeneic Bone-marrow Derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Musculoskeletal Injuries and/or Degeneration NCT06074783Phase 1, Phase 21 site📍 Nassau Cellcolabs Clinical LTD. · Tests: Human Allogeneic Bone-Marrow (BM) -Derived Mesenchymal Stromal Cells (MSCs) Product (StromaForte) Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients NCT06730009Phase 1, Phase 21 site📍 Tainan Medigen Biotechnology Corporation · Tests: SLOG + Allogeneic NK cell, SLOG chemotherapy Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site📍 Shenzhen Beijing Biotech · Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML NCT05807932Phase 1, Phase 26 sites📍 Aachen📍 Düsseldorf📍 Cologne Heinrich-Heine University, Duesseldorf · Tests: Venetoclax, Amsacrine, Ara-C, Tacrolimus, Mycophenolate Mofetil Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant NCT06315309Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: ATG Combined with Tacrolimus and Mini Methotrexate A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus NCT07444307Phase 13 sites📍 Hefei📍 Wuhan📍 Beijing Hangzhou Qihan Biotech Co., Ltd. · Tests: QT-019B Cell Injection Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients NCT06918834Phase 25 sites📍 Beijin📍 Zhengzhou📍 Jinan Institute of Hematology & Blood Diseases Hospital, China · Tests: Immediate HSCT Group, Bridging Therapy Group Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant NCT06543381Phase 12 sites📍 Duarte📍 Cleveland City of Hope Medical Center · Tests: Biospecimen Collection, Olutasidenib A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors NCT06730659Phase 11 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: CHT101 Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients NCT06147986Phase 21 site📍 Taichung Ever Supreme Bio Technology Co., Ltd. · Tests: Allogeneic umbilical cord mesenchymal stem cells, Control group CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. NCT06733610Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: universal allogeneic anti-CD19/BCMA CAR T-cells Forced Oscillatory Technique for Bronchiolitis Obliterans Syndrome After Allogeneic Bone Marrow Transplantation NCT07730931NA1 site📍 Jerusalem Hadassah Medical Organization · Tests: FOT - Forced Oscillation Technique A Study of B2065 in Patients With Acute Ischemic Stroke NCT07371624Phase 1, Phase 21 site📍 Beijing Tasly Pharmaceutical Group Co., Ltd · Tests: B2065, Placebo Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML. NCT06483906Phase 21 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Venetoclax, Azacitidine and Homoharringtonine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy